This presentation demonstrates a new treatment solution for the enhancement of inadequate alveolar bone volume. This sterile, antigen-inactivated mineralized block allograft offers a safe and unlimited source of “off-the-shelf” bone and significantly reduces the need for autogenous bone and a secondary surgical site. The new mineralized block allograft allows for the restoration of alveolar bone height and width for the functional and esthetic placement of dental implant restorations.
John E. Davies, BDS, PhD, DSc, who trained as an oromaxillofacial surgeon, is a professor of dentistry and biomaterials at the University of Toronto. Dr Davies devised the first in vitro biologic methods to study the mechanisms of bone bonding to bioactive ceramics, leading to an understanding of the mechanisms by which bone grows on implant surfaces and within tissue engineering scaffolds. He has developed ceramics that can be resorbed by osteoclasts, calcium phosphates that stimulate increase in local bone mass, scaffolding materials for bone regeneration, and extra-embryonic cells as a potential source of cell-based connective tissue repair. He was elected a fellow of Biomaterials Science and Engineering and received the Society for Biomaterials Clemson Award for Basic Science.